![Influence of Kidney Function Estimation Methods on Eligibility for Edoxaban Population Impact of the US Food and Drug Administration’s Approach for Its Product Labeling]()
Influence of Kidney Function Estimation Methods on Eligibility for Edoxaban Population Impact of the US Food and Drug Administration’s Approach for Its Product LabelingPokorney, Sean D.; Shrader, Peter; Thomas, Laine; Fonarow, Gregg C.; Kowey, Peter R.; Singer, Daniel E.; Ansell, Jack; Gersh, Bernard J; Mahaffey, Kenneth W.; Hylek, Elaine M.; Go, Alan S.; Piccini, Jonathan P.; Peterson, Eric D. · Circulation · 2016